Lantheus Holdings, Inc. is 2.8x more valuable than Celldex Therapeutics, Inc. by market capitalization ($6.67 B vs $2.35 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLDX | LNTH |
|---|---|---|
| Market cap | $2.35 B | $6.67 B |
| US-listed rank | #1990 | #1193 |
| Revenue (latest FY) | $1.54M | $1.54B |
| Net income (latest FY) | -$258.76M | $233.56M |
| Net margin | -16748.0% | 15.2% |
| P/E (trailing FY) | - | 28.6 |
| SEC filings | 1,268 | 1,079 |
Lantheus Holdings, Inc. is 2.8x more valuable than Celldex Therapeutics, Inc. by market capitalization ($6.67 B vs $2.35 B).
In their latest fiscal years, Celldex Therapeutics, Inc. reported $1.54M in revenue while Lantheus Holdings, Inc. reported $1.54B.
Full pages: Celldex Therapeutics, Inc. and Lantheus Holdings, Inc., or browse the full rankings.